Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | ATV-1601 |
| Synonyms | |
| Therapy Description |
ATV-1601 inhibits AKT1 E17K, potentially resulting in decreased tumor growth (Cancer Res (2025) 85 (8_Supplement_2): LB008). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| ATV-1601 | ATV 1601|ATV1601 | Akt1 Inhibitor 8 | ATV-1601 inhibits AKT1 E17K, potentially resulting in decreased tumor growth (Cancer Res (2025) 85 (8_Supplement_2): LB008). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT07038369 | Phase I | ATV-1601 + Fulvestrant ATV-1601 | A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations | Recruiting | USA | ESP | 0 |